Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.
Other companies in Structure Therapeutics’s space includes: WAVE Life Sciences Ltd (NASDAQ:WVE), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Terns Pharmaceuticals Inc (NASDAQ:TERN) and Axsome Therapeutics Inc (NASDAQ:AXSM).
Structure Therapeutics has a consensus price target of $88.81.
The stock price for Structure Therapeutics (NASDAQ: GPCR) is $61.6 last updated December 16, 2025 at 7:23 PM EST.
There are no upcoming dividends for Structure Therapeutics.
Structure Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Structure Therapeutics.
Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.